Comparison Crescent Biopharma (CBIO) with Competitors
Crescent Biopharma (CBIO) industry is Biotechnology.
Operating Margin
CBIO-2380.00%
Industry-2073.25%
Upside-306.75%
Free Cash Flow Yield
CBIO-13.33%
Industry-1.94%
Upside-11.39%
P/E
CBIO-4.13
Industry-18.88
Upside+1474.49%
P/S
CBIO49.82
Industry9.28
Upside+436.73%
P/B
CBIO3.28
Industry4.70
Upside-30.15%